norm: jasper therapeuticsManufacturingno LEI · CIK 0001788028Max severity: Low

Canonical registry

Jasper Therapeutics, Inc.

ent_b6f20eb3c3eb97d7b6dcef4e

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Jasper Therapeutics, Inc.
Normalized: jasper therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001788028
Domain: jaspertherapeutics.com

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-04-30
This is a Form 10-K/A (Amendment No. 1) filed by Jasper Therapeutics, Inc. (Nasdaq: JSPR) on April 30, 2026, amending the Annual Report for fiscal year ended December 31, 2025. The amendment solely adds Part III (Items 10–14) governance disclosures omitted from the original 10-K. No cybersecurity incident or breach is disclosed in this filing.